ArticleFrontiers in oncology2022

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.